Ambrx Biopharma Inc.

NYSE: AMAM · Real-Time Price · USD
28.00
0.02 (0.07%)
At close: Mar 06, 2024, 10:00 PM

Ambrx Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.12 -2.7
PEG Ratio
0.03 -0.00
PS Ratio
11.84 24.77
PB Ratio
0.74 0.97
P/FCF Ratio
-1.26 -3.86
P/OCF Ratio
-1.28 -4.14
OCF/S Ratio
-9.28 -5.99
Debt / Equity Ratio
0.10 0.07
Quick Ratio
5.21 6.98
Current Ratio
5.44 7.19
Asset Turnover
0.05 0.03
Interest Coverage
-58.97 n/a
Return on Equity
-0.66 -0.36
Return on Assets
-0.53 -0.3
Return on Invested Capital
-0.44 -0.31
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
1.00 1.00
Net Profit Margin
-10.54 -9.16
Pretax Profit Margin
-10.28 -9.16
Operating Profit Margin
-7.71 -8.64
FCF Margin
n/a n/a
EBITDA Margin
-7.54 -8.35